DanaLukinMDPhD
Gastroenterology • New York, NYInflammatory Bowel Disease
Associate Professor of Medicine
Overview of Dr. Lukin
Dr. Dana Lukin is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, Montefiore Medical Center, and NewYork-Presbyterian/Lower Manhattan Hospital. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 9 years. He is one of 112 doctors at Montefiore Medical Center and one of 300 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He also speaks multiple languages, including Spanish. He has more than 60 publications and over 500 citings.
Office
1283 York Avenue
9th Floor
New York, NY 10065
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2007 - 2010- Icahn School of Medicine at Mount SinaiClass of 2007, MD, PhD
Certifications & Licensure
NY State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- The Impact of Time Restricted Feeding in Crohn's Disease Start of enrollment: 2021 Jan 14
- Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients Start of enrollment: 2021 Feb 04
Publications & Presentations
PubMed
- Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy.Rochelle Wong, Paris Charilaou, Amy Hemperly, Lihui Qin, Yushan Pan
Crohn's & Colitis 360. 2024-10-01 - 5 citationsUpadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.Laurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, Raja Atreya, David T Rubin
Clinical Gastroenterology and Hepatology. 2024-10-01 - The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.Emily S Smith, Johnson Chen, Yushan Pan, Prerna Mahtani, Dana Lukin
Journal of Clinical Gastroenterology. 2024-07-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Press Mentions
Inpatient Monitoring May Extend Hospital Stays in Acute Severe Ulcerative ColitisJuly 30th, 2024- Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative ColitisDecember 2nd, 2022
- Higher Risk for Treatment Failure with Vedolizumab in Older IBD PatientsSeptember 30th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
